GlaxoSmithKline PLC
F:GS7A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GlaxoSmithKline PLC
F:GS7A
|
UK |
|
Multi Commodity Exchange of India Ltd
NSE:MCX
|
IN |
|
R
|
Reinet Investments SCA
F:RNT
|
LU |
|
Lumine Group Inc
F:Z76
|
CA |
|
BriQ Properties REIC
F:BRW
|
GR |
|
T
|
Twin Disc Inc
F:TWN
|
US |
|
Atlas Salt Inc
F:9D00
|
CA |
|
Grupo Rotoplas SAB de CV
OTC:GRPRF
|
MX |
|
Sabina Gold & Silver Corp
TSX:SBB
|
CA |
|
Predictiv AI Inc
XTSX:PAI
|
CA |
|
T
|
TriStar Gold Inc
F:7TG
|
US |
|
BMO Commercial Property Trust Ltd
LSE:BCPT
|
GG |
|
Pc Partner Group Ltd
OTC:PCPPF
|
HK |
|
E
|
Energenta AG
XMUN:EM6
|
DE |
|
S
|
Stockmann Oyj Abp
F:SOMB
|
FI |
Wall St Price Targets
GS7A Price Targets Summary
GlaxoSmithKline PLC
According to Wall Street analysts, the average 1-year price target for GS7A is 35.6 EUR with a low forecast of 24.88 EUR and a high forecast of 48.9 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GS7A's stock price target?
Price Target
35.6
EUR
According to Wall Street analysts, the average 1-year price target for GS7A is 35.6 EUR with a low forecast of 24.88 EUR and a high forecast of 48.9 EUR.
What is the Revenue forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Net Income forecast for GlaxoSmithKline PLC?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 4%.
